The crystal structure of the tumor suppressor protein pp32 (Anp32a): Structural insights into Anp32 family of proteins

Protein Science

Volumn 16, Issue 7, 2007, Pages 1308-1315

  Huyton, Trevor ^a   Wolberger, Cynthia ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anp32; Crystal structure; LRR; PHAPI; pp32

Indexed keywords

ACIDIC NUCLEAR PHOSPHOPROTEIN 32A; LEUCINE RICH REPEAT KINASE 2; PHOSPHOPROTEIN; PHOSPHOPROTEIN 32; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BIOCHEMICAL COMPOSITION; CRYSTAL STRUCTURE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY;

AMINO ACID SEQUENCE; CRYSTALLOGRAPHY, X-RAY; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 34250802262     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1110/ps.072803507     Document Type: Article

References (50)

1. Adegbola, O. and Pasternack, G.R. 2005. Phosphorylated retinoblastoma protein complexes with pp32 and inhibits pp32-mediated apoptosis. J. Biol. Chem. 280: 15497-15502.
2. Bai, J., Brody, J.R., Kadkol, S.S., and Pasternack, G.R. 2001. Tumor suppression and potentiation by manipulation of pp32 expression. Oncogene 20: 2153-2160.
3. Baker, N.A., Sept, D., Joseph, S., Holst, M.J., and McCammon, J.A. 2001. Electrostatics of nanosystems: Application to microtubules and the ribosome. Proc. Natl. Acad. Sci. 98: 10037-10041.
4. Brennan, C.M., Gallouzi, I.E., and Steitz, J.A. 2000. Protein ligands to HuR modulate its interaction with target mRNAs in vivo. J. Cell Biol. 151: 1-14.
5. Brody, J.R., Kadkol, S.S., Mahmoud, M.A., Rebel, J.M., and Pasternack, G.R. 1999. Identification of sequences required for inhibition of oncogene-mediated transformation by pp32. J. Biol. Chem. 274: 20053-20055.
6. Ceulemans, H., De Maeyer, M., Stalmans, W., and Bollen, M. 1999. A capping domain for LRR protein interaction modules. FEBS Lett. 456: 349-351.
7. Chen, T.H., Brody, J.R., Romantsev, F.E., Yu, J.G., Kayler, A.E., Voneiff, E., Kuhajda, F.P., and Pasternack, G.R. 1996. Structure of pp32, an acidic nuclear protein which inhibits oncogene-induced formation of transformed foci. Mol. Biol. Cell 7: 2045-2056.
8. Emsley, P. and Cowtan, K. 2004. Coot: Model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60: 2126-2132.
9. Esnouf, R.M. 1997. An extensively modified version of MolScript that includes greatly enhanced coloring capabilities. J. Mol. Graph. Model. 15: 132-134, 112-133.
10. Gallouzi, I.E., Brennan, C.M., and Steitz, J.A. 2001. Protein ligands mediate the CRM1-dependent export of HuR in response to heat shock. RNA 7: 1348-1361.
11. Gouet, P., Courcelle, E., Stuart, D.I., and Metoz, F. 1999. ESPript: Analysis of multiple sequence alignments in PostScript. Bioinformatics 15: 305-308.
12. Holm, L. and Sander, C. 1994. Searching protein structure databases has come of age. Proteins 19: 165-173.
13. Howitt, J.A., Clout, N.J., and Hohenester, E. 2004. Binding site for Robo receptors revealed by dissection of the leucine-rich repeat region of Slit. EMBO J. 23: 4406-4412.
14. Itin, C., Ulitzur, N., Muhlbauer, B., and Pfeffer, S.R. 1999. Mapmodulin, cytoplasmic dynein, and microtubules enhance the transport of mannose 6-phosphate receptors from endosomes to the trans-golgi network. Mol. Biol. Cell 10: 2191-2197.
15. Jiang, X., Kim, H.E., Shu, H., Zhao, Y., Zhang, H., Kofron, J., Donnelly, J., Burns, D., Ng, S.C., Rosenberg, S., et al. 2003. Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway. Science 299: 223-226.
16. Kadkol, S.S., El Naga, G.A., Brody, J.R., Bai, J., Gusev, Y., Dooley, W.C., and Pasternack, G.R. 2001. Expression of pp32 gene family members in breast cancer. Breast Cancer Res. Treat. 68: 65-73.
17. Kobe, B. and Deisenhofer, J. 1995. A structural basis of the interactions between leucine-rich repeats and protein ligands. Nature 374: 183-186.
18. Kobe, B. and Kajava, A.V. 2001. The leucine-rich repeat as a protein recognition motif. Curr. Opin. Struct. Biol. 11: 725-732.
19. Li, M. and Damuni, Z. 1998. I1PP2A and I2PP2A. Two potent protein phosphatase 2A-specific inhibitor proteins. Methods Mol. Biol. 93: 59-66.
20. Li, M., Guo, H., and Damuni, Z. 1995. Purification and characterization of two potent heat-stable protein inhibitors of protein phosphatase 2A from bovine kidney. Biochemistry 34: 1988-1996.
21. Li, M., Makkinje, A., and Damuni, Z. 1996. Molecular identification of I1PP2A, a novel potent heat-stable inhibitor protein of protein phosphatase 2A. Biochemistry 35: 6998-7002.
22. Lieberman, J. and Fan, Z. 2003. Nuclear war: The granzyme A-bomb. Curr. Opin. Immunol. 15: 553-559.
23. Liker, E., Fernandez, E., Izaurralde, E., and Conti, E. 2000. The structure of the mRNA export factor TAP reveals a cis arrangement of a non-canonical RNP domain and an LRR domain. EMBO J. 19: 5587-5598.
24. Malek, S.N., Katumuluwa, A.I., and Pasternack, G.R. 1990. Identification and preliminary characterization of two related proliferation-associated nuclear phosphoproteins. J. Biol. Chem. 265: 13400-13409.
25. Matilla, A. and Radrizzani, M. 2005. The Anp32 family of proteins containing leucine-rich repeats. Cerebellum 4: 7-18.
26. Matilla, A., Koshy, B.T., Cummings, C.J., Isobe, T., Orr, H.T., and Zoghbi, H.Y. 1997. The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1. Nature 389: 974-978.
27. Matsuoka, K., Taoka, M., Satozawa, N., Nakayama, H., Ichimura, T., Takahashi, N., Yamakuni, T., Song, S.Y., and Isobe, T. 1994. A nuclear factor containing the leucine-rich repeats expressed in murine cerebellar neurons. Proc. Natl. Acad. Sci. 91: 9670-9674.
28. Mencinger, M., Panagopoulos, I., Contreras, J.A., Mitelman, F., and Aman, P. 1998. Expression analysis and chromosomal mapping of a novel human gene, APRIL, encoding an acidic protein rich in leucines. Biochim. Biophys. Acta 1395: 176-180.
29. Merritt, E.A. and Murphy, M.E. 1994. Raster3D Version 2.0. A program for photorealistic molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 50: 869-873.
30. Murshudov, G.N., Vagin, A.A., and Dodson, E.J. 1997. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 53: 240-255.
31. Mutai, H., Toyoshima, Y., Sun, W., Hattori, N., Tanaka, S., and Shiota, K. 2000. PAL31, a novel nuclear protein, expressed in the developing brain. Biochem. Biophys. Res. Commun. 274: 427-433.
32. Nabors, L.B., Furneaux, H.M., and King, P.H. 1998. HuR, a novel target of anti-Hu antibodies, is expressed in non-neural tissues. J. Neuroimmunol. 92: 152-159.
33. Opal, P., Garcia, J.J., Propst, F., Matilla, A., Orr, H.T., and Zoghbi, H.Y. 2003. Mapmodulin/leucine-rich acidic nuclear protein binds the light chain of microtubule-associated protein 1B and modulates neuritogenesis. J. Biol. Chem. 278: 34691-34699.
34. Opal, P., Garcia, J.J., McCall, A.E., Xu, B., Weeber, E.J., Sweatt, J.D., Orr, H.T., and Zoghbi, H.Y. 2004. Generation and characterization of LANP/pp32 null mice. Mol. Cell. Biol. 24: 3140-3149.
35. Price, S.R., Evans, P.R., and Nagai, K. 1998. Crystal structure of the spliceosomal U2B″-U2A′ protein complex bound to a fragment of U2 small nuclear RNA. Nature 394: 645-650.
36. Rozenblum, E., Schutte, M., Goggins, M., Hahn, S.A., Panzer, S., Zahurak, M., Goodman, S.N., Sohn, T.A., Hruban, R.H., Yeo, C.J., et al. 1997. Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res. 57: 1731-1734.
37. Schneider, R., Bannister, A.J., Weise, C., and Kouzarides, T. 2004. Direct binding of INHAT to H3 tails disrupted by modifications. J. Biol. Chem. 279: 23859-23862.
38. Schubert, W.D., Urbanke, C., Ziehm, T., Beier, V., Machner, M.P., Domann, E., Wehland, J., Chakraborty, T., and Heinz, D.W. 2002. Structure of internalin, a major invasion protein of Listeria monocytogenes, in complex with its human receptor E-cadherin. Cell 111: 825-836.
39. Schulman, B.A., Carrano, A.C., Jeffrey, P.D., Bowen, Z., Kinnucan, E.R., Finnin, M.S., Elledge, S.J., Harper, J.W., Pagano, M., and Pavletich, N.P. 2000. Insights into SCF ubiquitin ligases from the structure of the Skp1-Skp2 complex. Nature 408: 381-386.
40. Scott, P.G., McEwan, P.A., Dodd, C.M., Bergmann, E.M., Bishop, P.N., and Bella, J. 2004. Crystal structure of the dimeric protein core of decorin, the archetypal small leucine-rich repeat proteoglycan. Proc. Natl. Acad. Sci. 101: 15633-15638.
41. Scott, P.G., Dodd, C.M., Bergmann, E.M., Sheehan, J.K., and Bishop, P.N. 2006. Crystal structure of the biglycan dimer and evidence that dimerization is essential for folding and stability of class I small leucine-rich repeat proteoglycans. J. Biol. Chem. 281: 13324-13332.
42. Seo, S.B., Macfarlan, T., McNamara, P., Hong, R., Mukai, Y., Heo, S., and Chakravarti, D. 2002. Regulation of histone acetylation and transcription by nuclear protein pp32, a subunit of the INHAT complex. J. Biol. Chem. 277: 14005-14010.
43. Thompson, J.D., Higgins, D.G., and Gibson, T.J. 1994. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22: 4673-4680.
44. Uff, S., Clemetson, J.M., Harrison, T., Clemetson, K.J., and Emsley, J. 2002. Crystal structure of the platelet glycoprotein Ib(alpha) N-terminal domain reveals an unmasking mechanism for receptor activation. J. Biol. Chem. 277: 35657-35663.
45. Ulitzur, N., Humbert, M., and Pfeffer, S.R. 1997a. Mapmodulin: A possible modulator of the interaction of microtubule-associated proteins with microtubules. Proc. Natl. Acad. Sci. 94: 5084-5089.
46. Ulitzur, N., Rancano, C., and Pfeffer, S.R. 1997b. Biochemical characterization of mapmodulin, a protein that binds microtubule-associated proteins. J. Biol. Chem. 272: 30577-30582.
47. Vaesen, M., Barnikol-Watanabe, S., Gotz, H., Awni, L.A., Cole, T., Zimmermann, B., Kratzin, H.D., and Hilschmann, N. 1994. Purification and characterization of two putative HLA class II associated proteins: PHAPI and PHAPII. Biol. Chem. Hoppe Seyler 375: 113-126.
48. Vagin, A. and Teplyakov, A. 2000. An approach to multi-copy search in molecular replacement. Acta Crystallogr. D Biol. Crystallogr. 56: 1622-1624.
49. Weinberg, R.A. 1995. The retinoblastoma protein and cell cycle control. Cell 81: 323-330.
50. Winn, M.D., Murshudov, G.N., and Papiz, M.Z. 2003. Macromolecular TLS refinement in REFMAC at moderate resolutions. Methods Enzymol. 374: 300-321.